Xencor | Salgsomkostninger Og Administration



Selling And Administration Expenses Lave om Dato
AbbVie USD 3.29B 562M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amgen USD 1.69B 191M 2025-03
Arrowhead Research USD 30.2M 1.91M 2024-12
AstraZeneca USD 3.59B 1.96B 2025-03
Biogen USD 572.5M 104.8M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Cytokinetics USD 62.34M 5.69M 2024-12
GlaxoSmithKline GBP 2.06B 603M 2025-03
J&J USD 5.11B 1.34B 2025-03
MacroGenics USD 27.81M 13.71M 2024-12
Merck USD 2.53B 319M 2025-03
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.01B 1.27B 2025-03
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Xencor USD 14.92M 148K 2024-12



Xencor Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2025.